Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin glargine (toujeo) (1 trial)
insulin glulisine (Apidra) (1 trial)
insulin human (humulin) (1 trial)
COVID-19 convalescent plasma (1 trial)
ivermectin (stromectol) (1 trial)
Diabetes Mellitus (Phase 4)
Hyperglycemia (Phase 4)
Trials (3 total)
Trial APIs (5 total)